Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine
Marc Weiner(The University of Texas at San Antonio Health Science Center), Thomas Hodge(Centers for Disease Control and Prevention), Andrew Vernon(Centers for Disease Control and Prevention), Awal Khan(University of North Texas), Barbara King(University of North Texas), Debra Benator(George Washington University), William J. Burman(Case Western Reserve University), N. P. Shah(University of North Texas), Stephen E. Weis(University of North Texas), Charles A. Peloquin(University of Florida)
Cited by 193
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548